Cancer And Vitamin C Treatment – The University Buses Are Arriving

They say London buses take a while to appear and then suddenly two come along at once.  It’s a bit like that with the ‘Vitamin C is effective to treat cancer’ mantra.  Last month two Universities, on both sides of The Pond, came along with successful clinical trials. Intravenous Vitamin C has an ability to treat cancer due to its’ ability to restrict angiogenesis (new blood vessel growth) in tumours and the evidence is building.

But, the Vitamin C cancer treatment idea is not new: three decades ago the wheels temporarily came off the Vitamin C Cancer Bus, despite the best efforts of Nobel Prize Winner, Dr Linus Pauling.  Such ‘free radical thinkers’ usually wait a lifetime to see their ideas escape out of the lab.  Fast forward to 2017 and maybe now we really do have a more welcoming environment, with multiple cancer rates at an all time high.  Last month the University of Iowa announced the results of a relatively inexpensive approach to treating brain and lung cancer tumours.  “These two diseases really haven’t had a significant improvement in outcomes for two or three decades”, says Bryan Allen, UI Assistant Professor of Radiation Oncology and an author on the study.  “This is a well-tolerated, very cost-effective treatment, and it may significantly improve patient outcomes”.

Meanwhile, published last month in Oncotarget was a University of Salford study lead by Professor Michael P. Lisanti with Dr Gloria Bonuccelli.  They found that: ‘Vitamin C is up to 10 times more effective at stopping cancer cell growth than some drugs’.  Now that’s more than juicy – it’s fuel for a whole fleet of buses.  A new era and one increasingly where the patient is the fully involved driver.